WebHenry O. Gosebruch is on the board of Aptinyx, Inc. and Chief Strategy Officer & Executive Vice President at AbbVie, Inc. In his past career he held the position of Co-Head-Mergers & Acquisitions North America at JPMorgan Securities LLC. Henry O. Gosebruch received an undergraduate degree from The Wharton School of the University of Pennsylvania. Web8 jan. 2024 · Henry O. Gosebruch, Executive Vice President, Chief Strategy Officer; Robert A. Michael, Executive Vice President, Chief Financial Officer; Timothy J. …
Henry O Gosebruch Net Worth (2024) - GuruFocus.com
Web20 jun. 2024 · The estimated Net Worth of Henry O Gosebruch is at least $16.9 Million dollars as of 16 May 2024. Mr. Gosebruch owns over … Web19 aug. 2024 · Abbvie Inc (ABBV) EVP, Chief Strategy Officer Henry O Gosebruch Bought $2 million of Shares GuruFocus • 07/31/19 5 Things You Need to Know From AbbVie's Q2 Earnings Results The Motley Fool • 07/26/19 AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q2 2024 Results - Earnings Call Transcript Seeking Alpha • 07/26/19 poissonnerie levallois
ABBVIE Bedrijfsgegevens Het Financieele Dagblad
WebOf aanmelden met Google Twitter Web30 mrt. 2024 · Mr. Gosebruch brings extensive industry experience to ACELYRIN, most recently serving as Executive Vice President and Chief Strategy Officer at AbbVie, a global biopharmaceutical company, from 2015 to February 2024.As a member of AbbVie's Executive Team, he was responsible for corporate strategy, business development and … WebFounder of Aptinyx, Inc., Norbert G. Riedel holds the position of Executive Chairman at Aptinyx, Inc. and Chairman for Eton Pharmaceuticals, Inc. He is also Member of Osterreichische Akademie Der... poissonnerie vaison la romaine